Clinical Research Expertise, Start-Up Precision, Operational Excellence
~
Clinical Research Expertise, Start-Up Precision, Operational Excellence ~
“I founded Precision Horizons to help Sponsors, CRO’s and Research Sites navigate operational complexity with confidence, prevision, and a commitment to quality.”
Hello, and thank you for visiting Precision Horizons Clinical Site Management, LLC.
My name is Joann E. Lawton, Founder and Principal Consultant of Precision Horizons. With more than 15 years of healthcare and clinical research experience, I have partnered with sponsors, CROs, biotechnology companies, and research sites to support study startup, site activation, regulatory compliance, and clinical operations across a wide range of therapeutic areas.
Throughout my career, I have seen firsthand the challenges organizations face when balancing ambitious timelines, regulatory requirements, limited resources, and operational complexity. Precision Horizons was founded to provide experienced, hands-on support that helps clients navigate those challenges while maintaining quality, compliance, and operational excellence.
At Precision Horizons, we focus on practical execution, proactive communication, and strategic partnership. Whether supporting a single study or a broader operational initiative, our goal is to reduce startup delays, strengthen compliance, improve operational efficiency, and help clients achieve study milestones with confidence.
We believe successful clinical research is built on three principles:
Collaboration. Communication. Execution.
Because clinical trials don't move forward through planning alone. They move forward through strong partnerships, operational excellence, and a commitment to getting the details right.
Precision in Operations. Confidence in Execution.
-
15+ Years Healthcare & Clinical Research Experience
Phase I-IV Clinical Trial Experience
North America, Canada, Puerto Rico & LATAM Experience
Sponsor, CRO & Research Site Expertise
Study Startup Through Closeout Support
Regulatory, Operational & Quality Oversight Experience
Vendor Management & Cross-Functional Leadership
Inspection Readiness & TMF Quality Focus
-
Extensive experience supporting Phase I-IV clinical trials across startup, activation, execution, quality oversight, regulatory compliance, enrollment support, inspection readiness, and study closeout activities. Experienced partnering with sponsors, CROs, biotechnology companies, and research sites to deliver operational excellence throughout the clinical trial lifecycle.
-
Extensive experience supporting Phase I-IV clinical trials across a broad range of therapeutic areas, including:
Allergy & Immunology, Cardiology, Dermatology, Endocrinology & Metabolic Disorders, Family Practice, Gastroenterology, Infectious Disease, Internal Medicine, MASH/MASLD, Medical Devices, Nephrology, Neurology, Obesity, OB-GYN, Oncology, Ophthalmology, Orthopedics, Pain Management, Pulmonary & Respiratory, Rheumatology, Sleep Medicine, Smoking Cessation, Urology, and Vaccines.
-
Extensive experience supporting IRB/IEC submissions, informed consent review, essential document collection, regulatory package preparation, TMF quality review, inspection readiness, site activation planning, protocol implementation, startup risk mitigation, and study startup execution across global clinical trials.
-
Experience supporting clinical trial budget development, contract review, startup forecasting, investigator payment processes, sponsor invoicing, confidentiality agreements (CDAs), data use agreements (DUAs), and study startup financial planning activities. Collaborated with sponsors, CROs, legal teams, and contracting departments to facilitate contract execution, budget negotiations, and activation timelines.
-
Experience supporting recruitment planning, enrollment forecasting, patient engagement strategies, pre-screening workflows, community outreach initiatives, retention planning, and site-level recruitment optimization. Strong understanding of enrollment challenges and operational strategies designed to improve study participation and retention.